Literature DB >> 14657812

Newborn screening for cystic fibrosis: ensuring more good than harm.

Michael H Farrell1, Philip M Farrell.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14657812     DOI： 10.1016/j.jpeds.2003.09.022

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  16 in total

1.  Psychosocial Distress and Knowledge Deficiencies in Parents of Children in Ireland Who Carry an Altered Cystic Fibrosis Gene.

Authors:  S J Quigley; B Linnane; S Connellan; A Ward; P Ryan
Journal:  J Genet Couns       Date:  2017-09-26       Impact factor: 2.537

2.  Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes.

Authors:  Don Hayes; Susan E West; Michael J Rock; Zhanhai Li; Mark L Splaingard; Philip M Farrell
Journal:  Pediatr Pulmonol       Date:  2010-07

Review 3.  Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy.

Authors:  Edith T Zemanick; J Kirk Harris; Steven Conway; Michael W Konstan; Bruce Marshall; Alexandra L Quittner; George Retsch-Bogart; Lisa Saiman; Frank J Accurso
Journal:  J Cyst Fibros       Date:  2009-10-14       Impact factor: 5.482

Review 4.  Newborn screening for cystic fibrosis.

Authors:  Jack K Sharp; Michael J Rock
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

Review 5.  Atypical cystic fibrosis and CFTR-related diseases.

Authors:  Shruti M Paranjape; Pamela L Zeitlin
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

6.  A method to assess the organizing behaviors used in physicians' counseling of standardized parents after newborn genetic screening.

Authors:  Stephanie A Christopher; Nadia Y Ahmad; Lisa Bradford; Jenelle L Collins; Kerry Eskra; Alison la Pean Kirschner; Faith O O'Tool; Sara J Roedl; Michael H Farrell
Journal:  Commun Med       Date:  2012

7.  Refining the continuum of CFTR-associated disorders in the era of newborn screening.

Authors:  H Levy; M Nugent; K Schneck; D Stachiw-Hietpas; A Laxova; O Lakser; M Rock; M K Dahmer; J Biller; S Z Nasr; M Baker; S A McColley; P Simpson; P M Farrell
Journal:  Clin Genet       Date:  2016-01-20       Impact factor: 4.438

8.  Frequency of high-quality communication behaviors used by primary care providers of heterozygous infants after newborn screening.

Authors:  Michael H Farrell; Stephanie A Christopher
Journal:  Patient Educ Couns       Date:  2012-11-26

9.  Impact of false-positive newborn metabolic screening results on early health care utilization.

Authors:  Ellen A Lipstein; James M Perrin; Susan E Waisbren; Lisa A Prosser
Journal:  Genet Med       Date:  2009-10       Impact factor: 8.822

10.  Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients.

Authors:  Lynn Pique; Steve Graham; Michelle Pearl; Martin Kharrazi; Iris Schrijver
Journal:  Genet Med       Date:  2016-05-05       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.